Arrestin-C Double Nickase Plasmid (h): sc-403284-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Arrestin-C Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- Arrestin-C Double Nickase Plasmid (h) and Arrestin-C Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting ARR3. One or both designs may be available
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Arrestin-C Antibody (2D7): sc-293296
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Arrestin-C Double Nickase Plasmid (h) | sc-403284-NIC | 20 µg | $410.00 | |||
Arrestin-C Double Nickase Plasmid (h2) | sc-403284-NIC-2 | 20 µg | $410.00 |
ARR3 encodes Arrestin-C (cone arrestin), a retina-enriched arrestin family adaptor that binds activated, phosphorylated cone opsins to terminate G protein signaling and promote receptor desensitization. By coordinating GPCR shutoff and contributing to receptor trafficking and compartmentalization, Arrestin-C helps tune phototransduction kinetics and light adaptation in cone photoreceptors. Disruption of ARR3 function is linked to retinal dysfunction and inherited visual phenotypes, making it relevant for studies of cone biology, opsin signaling regulation, and degeneration-associated stress responses. Its cell-type specificity also supports pathway mapping of arrestin-mediated signaling networks in human retinal models.
Arrestin-C Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the ARR3 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within ARR3. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt ARR3 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of ARR3-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.